They have raised millions in capital. They have d
Post# of 36537
(Total Views: 220)
Posted On: 02/09/2021 10:12:09 AM
They have raised millions in capital. They have deals totaling over 2 billion dollars and more deals that will be signed.
We are waiting now 5 - 8 days for test results to see if this will be a 'complete vaccine' or a booster, but from their own reports, they definitely have something.
They also have a wonderful cancer drug AE37 that the Chinese are interested in, not including that they will still have for the US, they have excellergen which they will be able to sell in the VA hospitals once they open back up.
They have the MSO they are working on in Arizona and other states and Arizona should start showing revenue by now.
So, all in all, the company should be moving forward.
Why would you even want to drop this to .05 and lose everything. My expectation is for this to go as high as possible and for everyone to benefit in the near future with a vaccine for Covid, for their work with Swine Flu, for Cancer, for Diabetes, for Excellagen and for everything else they are doing.
We are waiting now 5 - 8 days for test results to see if this will be a 'complete vaccine' or a booster, but from their own reports, they definitely have something.
They also have a wonderful cancer drug AE37 that the Chinese are interested in, not including that they will still have for the US, they have excellergen which they will be able to sell in the VA hospitals once they open back up.
They have the MSO they are working on in Arizona and other states and Arizona should start showing revenue by now.
So, all in all, the company should be moving forward.
Why would you even want to drop this to .05 and lose everything. My expectation is for this to go as high as possible and for everyone to benefit in the near future with a vaccine for Covid, for their work with Swine Flu, for Cancer, for Diabetes, for Excellagen and for everything else they are doing.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼